alendronate has been researched along with Arthropathy, Neurogenic in 4 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Arthropathy, Neurogenic: Chronic progressive degeneration of the stress-bearing portion of a joint, with bizarre hypertrophic changes at the periphery. It is probably a complication of a variety of neurologic disorders, particularly TABES DORSALIS, involving loss of sensation, which leads to relaxation of supporting structures and chronic instability of the joint. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " They differed markedly in study type, pharmacological agent used, dosing regimen, disease, aetiology/stage/location, concurrent off-loading regimen, outcomes and, follow-up." | 2.49 | A Surgeon's guide to advances in the pharmacological management of acute Charcot neuroarthropathy. ( Afsie, S; Al-Nammari, SS; Timothy, T, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Nammari, SS | 1 |
| Timothy, T | 1 |
| Afsie, S | 1 |
| Molines, L | 1 |
| Darmon, P | 1 |
| Raccah, D | 1 |
| Pitocco, D | 2 |
| Ruotolo, V | 2 |
| Caputo, S | 2 |
| Mancini, L | 2 |
| Collina, CM | 1 |
| Manto, A | 2 |
| Caradonna, P | 2 |
| Ghirlanda, G | 2 |
| Collina, MC | 1 |
| Musella, T | 1 |
| Galli, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Treatment With DENOsumab of an Acute CHARCOT Foot in Patients With Diabetes. A Multicenter, Double-blind, Randomized, Placebo-controlled Trial.[NCT04547348] | Phase 3 | 38 participants (Anticipated) | Interventional | 2020-11-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for alendronate and Arthropathy, Neurogenic
| Article | Year |
|---|---|
A Surgeon's guide to advances in the pharmacological management of acute Charcot neuroarthropathy.
Topics: Alendronate; Alkaline Phosphatase; Arthropathy, Neurogenic; Bone Density Conservation Agents; Calcit | 2013 |
Charcot's foot: newest findings on its pathophysiology, diagnosis and treatment.
Topics: Alendronate; Arthropathy, Neurogenic; Biomarkers; Bone Density Conservation Agents; Calcitonin; Diab | 2010 |
Interaction between IGF-1, inflammation, and neuropathy in the pathogenesis of acute charcot neuroarthropathy: lessons from alendronate therapy and future perspectives of medical therapy.
Topics: Acute Disease; Alendronate; Arthropathy, Neurogenic; Bone Density Conservation Agents; Bone Resorpti | 2008 |
1 trial available for alendronate and Arthropathy, Neurogenic
| Article | Year |
|---|---|
Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial.
Topics: Acute Disease; Alendronate; Arthropathy, Neurogenic; Bone Resorption; Diabetic Neuropathies; Disabil | 2005 |